title: Melatonin sensitizes human malignant glioma cells against TRAIL-induced cell death.
abstract: Despite the common expression of death receptors, many types of cancer including gliomas are resistant to the death receptor ligand (TRAIL). Melatonin antitumoral actions have been extensively described, including oncostatic properties on several tumor types and improvement of chemotherapeutic regimens. Here, we found that melatonin effectively increase cell sensitivity to TRAIL-induced cell apoptosis in A172 and U87 human glioma cells. The effect seems to be related to a modulation of PKC activity which in turns decreases Akt activation leading to an increase in death receptor 5 (DR5) levels and a decrease in the antiapoptotic proteins survivin and bcl-2 levels.
authors.affiliation: Departamento de Morfología y Biología Celular, Spain. martinvanesa@uniovi.es
authors.forename: Vanesa
authors.initials: V
authors.lastname: Martín
authors.forename: Guillermo
authors.initials: G
authors.lastname: García-Santos
authors.forename: Jezabel
authors.initials: J
authors.lastname: Rodriguez-Blanco
authors.forename: Sara
authors.initials: S
authors.lastname: Casado-Zapico
authors.forename: Ana
authors.initials: A
authors.lastname: Sanchez-Sanchez
authors.forename: Isaac
authors.initials: I
authors.lastname: Antolín
authors.forename: Maria
authors.initials: M
authors.lastname: Medina
authors.forename: Carmen
authors.initials: C
authors.lastname: Rodriguez
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects; D005910:Glioma / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D051034:Inhibitor of Apoptosis Proteins; D008550:Melatonin / Q000494:pharmacology*; D008869:Microtubule-Associated Proteins / Q000378:metabolism; D011493:Protein Kinase C / Q000378:metabolism; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism; D053220:Receptors, TNF-Related Apoptosis-Inducing Ligand / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects*; D000077022:Survivin; D053221:TNF-Related Apoptosis-Inducing Ligand / Q000494:pharmacology*
chemical_list: C107489:BIRC5 protein, human; D051034:Inhibitor of Apoptosis Proteins; D008869:Microtubule-Associated Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D053220:Receptors, TNF-Related Apoptosis-Inducing Ligand; D000077022:Survivin; D053221:TNF-Related Apoptosis-Inducing Ligand; D051057:Proto-Oncogene Proteins c-akt; D011493:Protein Kinase C; D008550:Melatonin